Oct 29, 2021
Laboratory testing is essential in the practice of psychopharmacology. For example, which parameters should be monitored in patients taking carbamazepine, TCAs, atypical antipsychotics, or esketamine?
Guest: Sandra Jacobson, M.D.;
Interviewer: Mohan Gautam., D.O.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.
Oct 24, 2021
This episode discusses technology-facilitated adherence enhancement, including text messaging, a wireless system to track adherence, and the evidence of technology-facilitated adherence for patients with bipolar disorder. It also addresses an ecological momentary intervention and the involvement of family in...
Oct 19, 2021
When a patient presents with markedly elevated temperature and altered mental status, is it neuroleptic malignant syndrome or serotonin syndrome? If you do not have a medication list, some clinical signs may help.
Faculty: Jim Phelps, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.
Oct 14, 2021
This episode discusses how to improve psychotropic drug adherence by targeting the reasons for nonadherence. It also discusses a 3-tiered approach to enhancing adherence, a patient questionnaire to evaluate the reasons for not taking medications, the top reasons for poor antipsychotic adherence, and the positive aspects...
Oct 9, 2021
How risky is esketamine? In this episode, we examine the safety of esketamine using postmarketing data that have been reported since the drug was approved and released.
Faculty: Jim Phelps, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.